Onder Ali Mirza, Chandar Jayanthi, Coakley Sheila, Abitbol Carolyn, Montane Brenda, Zilleruelo Gaston
Department of Pediatrics, Division of Pediatric Nephrology, Holtz Children's Hospital, University of Miami, Miami, FL 33101, USA.
Pediatr Nephrol. 2006 Oct;21(10):1452-8. doi: 10.1007/s00467-006-0130-6. Epub 2006 Aug 1.
Tunneled central venous catheters are often used in children on chronic hemodialysis. This study was done to evaluate the spectrum of catheter-related bacteremia (CRB) and to determine predictors of recurrent CRB in children on hemodialysis. Chart review was performed in 59 children from a pediatric dialysis unit with chronic, tunneled, cuffed hemodialysis catheters between January 1999 and December 2003. CRB was diagnosed in 48 of 59 (81%) patients. The incidence of CRB was 4.8/1,000 catheter days. Overall catheter survival (290+/-216 days) was significantly longer than infection-free catheter survival (210+/-167 days, p<0.05). Organisms isolated were gram-positive in 67%, gram-negative in 14%, and polymicrobial in 19%. Systemic antibiotics cleared CRB in 34% and an additional 23% cleared with the inclusion of antibiotic-heparin locks; 43% required catheter exchange. There was a significant likelihood of early catheter exchange with polymicrobial CRB (p<0.01). Catheter loss occurred from infection in 63%. Risk factors for CRB included young age (<10 years) and presence of human immunodeficiency virus (HIV) infection. Patients with >2 initial positive blood cultures (p<0.0001) had a significantly higher rate of recurrence after 6 weeks of initial treatment. In conclusion, CRB remains a major determinant of catheter loss. However, overall catheter survival is longer than infection-free catheter survival, suggesting that systemic antibiotics with antibiotic-heparin locks should be the initial step in the management of CRB and this approach may salvage some catheters.
隧道式中心静脉导管常用于接受慢性血液透析的儿童。本研究旨在评估导管相关菌血症(CRB)的范围,并确定血液透析儿童复发性CRB的预测因素。对1999年1月至2003年12月期间来自一家儿科透析单位的59名使用慢性、隧道式、带袖套血液透析导管的儿童进行了病历回顾。59例患者中有48例(81%)被诊断为CRB。CRB的发生率为4.8/1000导管日。导管总体存活时间(290±216天)显著长于无感染导管存活时间(210±167天,p<0.05)。分离出的微生物中,革兰氏阳性菌占67%,革兰氏阴性菌占14%,多微生物感染占19%。全身使用抗生素清除CRB的比例为34%,另外23%通过使用抗生素-肝素封管清除;43%需要更换导管。多微生物CRB患者早期更换导管的可能性显著增加(p<0.01)。63%的导管因感染而丢失。CRB的危险因素包括年龄小(<10岁)和人类免疫缺陷病毒(HIV)感染。初始血培养阳性>2次的患者(p<0.0001)在初始治疗6周后的复发率显著更高。总之,CRB仍然是导管丢失的主要决定因素。然而,导管总体存活时间长于无感染导管存活时间,这表明全身使用抗生素并联合抗生素-肝素封管应作为CRB管理的初始步骤,这种方法可能挽救一些导管。